Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE) is pleased to announce the appointment of experienced Chief Financial Officer, Mr Tony Di Pietro. Tony will also be appointed as Company Secretary upon his arrival.
Mr Di Pietro is a Chartered Accountant and an Associate of the Governance Institute Australia with 18 years
Biotechnology industry experience.
Morgan Stanley Maintains Equal-Weight on Jackson Finl, Lowers Price Target to $31
Morgan Stanley analyst Nigel Dally maintains Jackson Finl (NYSE:JXN) with a Equal-Weight and lowers the price target from $33 to $31.
